Home › Zacks Investment Research Upgrades Charles & Colvard, Ltd. (CTHR) to "Buy"
 

Keywords :   


Zacks Investment Research Upgrades Charles & Colvard, Ltd. (CTHR) to "Buy"

2016-01-05 02:13:15| Chemicals - Topix.net

The brokerage currently has a $1.25 price objective on the stock. Zacks Investment Research 's price objective would suggest a potential upside of 12.61% from the stock's previous close.

Tags: to buy research investment

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »
23.11 3
23.11
23.11GEN FACTORY CARVE7.7 2525.5
23.11110
23.11 ssp
23.11L
23.11
23.11 DVD-BOX6
More »